Indivior (LON:INDV) Trading Down 22.9% – What’s Next?

Indivior PLC (LON:INDV)’s share price dropped 22.9% during trading on Thursday . The company traded as low as GBX 548.71 ($6.90) and last traded at GBX 669.50 ($8.42). Approximately 1,917,540 shares were traded during trading, an increase of 170% from the average daily volume of 710,287 shares. The stock had previously closed at GBX 868 ($10.92).

Wall Street Analyst Weigh In

Separately, Jefferies Financial Group restated a “buy” rating and set a GBX 1,800 ($22.65) price objective on shares of Indivior in a research note on Tuesday, December 17th.

Indivior Price Performance

The firm has a market capitalization of £1.08 billion, a price-to-earnings ratio of -573.71, a P/E/G ratio of -5.57 and a beta of 0.19. The company’s 50 day moving average is GBX 928.06 and its 200-day moving average is GBX 853.71. The company has a current ratio of 0.83, a quick ratio of 1.52 and a debt-to-equity ratio of -170.06.

About Indivior

Indivior PLC, together with its subsidiaries, engages in the development, manufacture, and sale of buprenorphine-based prescription drugs for the treatment of opioid dependence and co-occurring disorders in the United States, the United Kingdom, and internationally. The company develops medicines to treat substance use disorders, serious mental illnesses, and opioid overdose.